Document Type
Article
Publication Date
9-30-2021
Abstract
Minimally invasive locoregional therapies have become important treatment options for patients with intermediate or late-stage hepatocellular carcinoma (HCC) who are ineligible for surgical resection or liver transplantation. Imaging modalities are essential for procedural guidance and for assessing treatment response thereafter. We report a unique finding of a patient with multifocal HCC treated with transarterial radioembolization (TARE) with yttrium-90 (Y90) and transarterial chemoembolization (TACE). We compared contrast-enhanced ultrasound (CEUS) with contrast-enhanced magnetic resonance imaging (CE-MRI) in the evaluation of treatment response to demonstrate advantages of CEUS imaging technique and its early detection of viable tumor.
Recommended Citation
Savsani, Esika; Tantawi, M.; Wessner, Corinne; Lee, Philip; Lyshchik, Andrej; Anton, Kevin; Shaw, Colette; Liu, Ji-Bin; and Eisenbrey, John R., "Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization" (2021). Department of Radiology Faculty Papers. Paper 116.
https://jdc.jefferson.edu/radiologyfp/116
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Language
English
Comments
This article is the author’s final published version in Advanced Ultrasound in Diagnosis and Therapy, Volume 5, Issue 3, September 2021, Pages 254-257
The published version is available at https://doi.org/10.37015/AUDT.2021.210018. Copyright © AUDT